Week of January 16, 2024 | Vol. 13, Issue 3

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company



Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable CDMO

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products

PR Newswire - Jan 8, 2024

2024 forecast: As CDMOs come off pandemic's highs and lows, employment and funding hitches persist

Fierce Pharma - Jan 8, 2024

FUJIFILM Diosynth Biotechnologies and SHL Medical Enter strategic partnership agreement to help meet growing market demand for autoinjector medicines

FUJIFILM - Jan 8, 2024

JPM24, Day 1: Even after M&A deals, BMS CEO focuses on pipeline; Amgen spotlights obesity prospects

Fierce Pharma -Jan 8, 2024

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

PR Newswire - Jan 9, 2024

JPM24, Day 2: GSK, Eli Lilly, Blueprint, SR One and more

Fierce Biotech - Jan 9, 2024

GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing

PR Newswire - Jan 9, 2024

Cereno, CordenPharma Enter CS1 Mfg. Pact

Contract Pharma - Jan 11, 2024

Fortrea, Veeva and Advarra in pact to streamline clinical trials

Fierce Biotech - Jan 9, 2024

TANNER NEWS

Improving Lives by Increasing Access to Medicines Around the World

New year, same goal ➡️ improve lives. Join the Tanner journey. Let’s find ways to improve patient lives, together.

https://www.youtube.com/watch?v=9dAJo8WKQFk